Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MICOS10 pseudogene 4 (MICOS10P4) is classified as a pseudogene that shares homology with the protein-coding MICOS10 gene, which is a component of the mitochondrial contact site and cristae organizing system (MICOS) complex[5]. Unlike its parent gene MICOS10, which encodes a subunit of the MICOS complex and is essential for mitochondrial cristae morphology and inner membrane architecture [3][1], MICOS10P4 does not produce a functional protein and has no proven role in health or disease. It is not considered a therapeutic target, nor is it known to interact with drugs or serve as a biomarker. Key point: MICOS10P4 is a nonfunctional genomic element (pseudogene) and should not be confused with MICOS10, which is an active protein-coding gene involved in mitochondrial structure and linked to certain mitochondrial diseases [1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MICOS10 pseudogene 4 (MICOS10P4).